Jonathan's BioJonathan Miller has more than a decade of experience in managing diverse medical research and development programs and appropriations in the defense health sector, and over 12 years of direct government experience leading all aspects of planning, programming, budgeting, and execution processes. He serves as a principal on the firm’s federal government relations team and primarily assists clients in the defense and defense health space.
Prior to joining Cornerstone, Jonathan served as chief of staff for the Defense Health Agency (DHA) Research and Development Directorate. In that capacity, he provided strategic direction and oversight of Defense Health Program (DHP) science and technology investments in the areas of combat casualty care, operational medicine, infectious diseases, medical simulation, health services, and clinical investigations. He also led multiple facets of DHA organizational transition activities, including the consolidation of military medical research and development across the Department of Defense. Before that, Jonathan served as the civilian deputy, Office of the Principal Assistant for Research and Technology at the U.S. Army Medical Research and Development Command (USAMRDC), Fort Detrick, MD. He also served as the director, DHP (Research, Development, Test, and Evaluation) responsible for ensuring that DHP medical research and development investments aligned with Military Health System policies and strategic goals and objectives.
Jonathan was the research portfolio manager for the Sensory System Traumatic Injury for the USAMRDC’s Clinical and Rehabilitative Medicine Research Program. His scientific research focused on the behavioral and molecular mechanisms of drugs of abuse and has been published in several peer-reviewed scientific journals. Additionally, he has published his legal research focused on biobanking, human subjects research protection, privacy law, and U.S. Food and Drug Administration regulations in peer-reviewed law journals. Jonathan received a B.S. in Nutrition from LaSalle University in 2002, M.S. in Biochemistry & Molecular Biology from Georgetown University in 2004, Ph.D. in Pharmacology from Temple University School of Medicine in 2009, and a J.D. from the University of Maryland, Francis King Carey School of Law in 2014. He is licensed to practice law in Maryland.